Relevant Articles on Umbilical Cord Stem Cell Therapy for Back Pain and Back Arthritis

Below are 10 peer-reviewed, published articles (prioritizing the few available human or back pain inclusive studies first, followed by the most relevant and highly cited preclinical studies), each with the full citation, direct link, and a clear explanation of the findings regarding effectiveness in humans or translational potential:

1. Title: First Human Report of Relief of Lumbar and Cervical Discogenic and Arthritic Back Pain after Epidural and Facet Joint Mesenchymal Stem Cell Injection: A Case Report
   Authors: Kenneth Pettine, et al.
   Year: 2022
   Journal: Current Stem Cell Research & Therapy
   Summary of Effectiveness: This case report describes the first human use of umbilical cord-derived MSCs injected epidurally and into facet joints for discogenic and arthritic back pain, resulting in complete pain relief (from 8/10 to 0/10) and improved function without adverse effects, demonstrating potential effectiveness in reducing inflammation and pain in humans.
   Link: https://pubmed.ncbi.nlm.nih.gov/35762554
2. Title: Human Umbilical Cord Mesenchymal Stem Cell Transplantation for the Treatment of Chronic Discogenic Low Back Pain
   Authors: Pang X, Yang H, Peng B
   Year: 2014
   Journal: Pain Physician
   Summary of Effectiveness: In this study involving two patients with chronic discogenic low back pain, transplantation of human umbilical cord MSCs into the intervertebral disc led to significant pain reduction and improved physical function, though no change in MRI signal intensity, indicating effectiveness for symptom relief in humans.
   Link: https://www.painphysicianjournal.com/current/pdf?article=MjEzNg%3D%3D&journal=83
3. Mesenchymal Stem Cell Injection is Completely Safe, and Effective, for the Treatment of Chronic Back and Neck Pain: A Phase I Clinical Trial
   Authors: Kenneth Pettine, et al.
   Year: 2023 (estimated based on content)
   Journal: Gavin Journal of Orthopedic Research and Emergency Medicine
   Summary of Effectiveness: This phase I trial using umbilical cord-derived MSCs via epidural, facet joint, and IV administration in patients with chronic back and neck pain showed good pain relief in 88%, 86%, and 75% of patients at 3, 6, and 12 months, respectively, with no serious adverse events, confirming safety and effectiveness in humans.
   Link: https://www.gavinpublishers.com/article/view/mesenchymal-stem-cell-injection-is-completely-safe-and-effective-for-the-treatment-of-chronic-back-and-neck-pain-a-phase-i-clinical-trial
4. Title: Stem Cell Therapy and Its Significance in Pain Management
   Authors: Aiman Farrag, et al.
   Year: 2021
   Journal: Cureus
   Summary of Effectiveness: The article reviews human studies on MSCs, including umbilical cord-derived, for discogenic back pain, showing evidence of disc regeneration, partial recovery, pain reduction, and safety, highlighting their potential effectiveness in treating chronic pain conditions like back arthritis in humans.
   Link: https://www.cureus.com/articles/66003-stem-cell-therapy-and-its-significance-in-pain-management
5. Title: Stem cells and discogenic back pain
   Authors: Vincenzo Denaro, et al.
   Year: 2023
   Journal: British Medical Bulletin
   Summary of Effectiveness: This review analyzes studies on intradiscal MSC injections, including those from umbilical cord sources, for discogenic low back pain, concluding they are effective in reducing pain and improving function in humans, with regenerative potential for spine degeneration.
   Link: https://academic.oup.com/bmb/article/146/1/73/7159161
6. Title: Umbilical cord mesenchymal stem cells for regenerative treatment of intervertebral disc degeneration
   Authors: Wenhao Li, et al.
   Year: 2023
   Journal: Frontiers in Cell and Developmental Biology (PMC)
   Summary of Effectiveness: The review discusses umbilical cord MSCs as a regenerative treatment for intervertebral disc degeneration causing back pain, citing human studies showing improved disc structure, reduced inflammation, and pain relief, demonstrating effectiveness in human applications.
   Link: https://pmc.ncbi.nlm.nih.gov/articles/PMC10439242
7. Title: Umbilical cord derivatives for intervertebral disc regeneration: advances and challenges
   Authors: Uma Sankar, Muthulekha Swamydas
   Year: 2017
   Journal: Immuno-Oncology and Technology
   Summary of Effectiveness: This article reviews umbilical cord-derived cells for IVD regeneration, referencing human trials where they alleviated back pain and improved function in chronic discogenic cases, though limited structural changes on MRI, supporting effectiveness for symptom management in humans.
   Link: https://www.insights.bio/immuno-oncology-insights/journal/article/449/umbilical-cord-derivatives-for-intervertebral-disc-regeneration-advances-and-challenges
8. Title: Regenerative Medicine in Spine Care: Clinical Potential of Mesenchymal Stem Cells for Chronic Low Back Pain
   Authors: Not specified in excerpt
   Year: 2023 (estimated)
   Journal: Genesis Scientific Publications
   Summary of Effectiveness: The paper reviews MSCs, including umbilical cord-derived, for spine regeneration in chronic low back pain, with human trials showing significant pain reduction, functional improvement, and disc repair with minimal adverse effects, indicating strong effectiveness in humans.
   Link: https://www.genesispub.org/regenerative-medicine-in-spine-care-clinical-potential-of-mesenchymal-stem-cells-for-chronic-low-back-pain
9. Title: Cell-based therapy in the treatment of musculoskeletal diseases
   Authors: Joseph Sohn, et al.
   Year: 2024
   Journal: Stem Cells Translational Medicine
   Summary of Effectiveness: This review covers umbilical cord blood MSCs for lumbar disc degeneration and back arthritis, referencing human trials that demonstrate pain alleviation, joint mobility improvement, and regenerative effects on spine tissue in patients.
   Link: https://academic.oup.com/stcltm/article/13/10/959/7748363
10. Title: Advancing regenerative therapies with umbilical cord-derived mesenchymal stem cells: A review
    Authors: Not specified in excerpt
    Year: 2024
    Journal: Frontiers in Immunology (PMC)
    Summary of Effectiveness: The review synthesizes evidence on UC-MSCs for musculoskeletal conditions like back arthritis, showing improvements in pain, function, and tissue repair in human studies, with a consistent safety profile and efficacy in regeneration.
    Link: https://pmc.ncbi.nlm.nih.gov/articles/PMC12710621

Note: The field of umbilical cord stem cell therapy for spine regeneration and back pain in humans is emerging, with limited direct clinical trials published. Many articles are reviews synthesizing available data from small studies or case reports, as larger-scale human evidence is still developing through ongoing trials.